Spherical vs Angular Silica: Which Filler Performs Better and When?

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: What Is Nano Silica? Particle Size, Properties, Production and Applications
  • Keywords: amorphous vs crystalline silica
  • Published: 2026-11-20 10:59:54
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals

Silica Filler for Plastics: Benefits, Grades and Applications

Silica Gel Beads: Types, Sizes, Indicating vs Non-Indicating and Uses
Considering these components, substantial efforts have been conducted to go for particular surface functionalization modifications of MSNs to decrease their toxicity such as neurotoxicity, immunotoxicity, and systemic toxicity (Fig. 6a ). A common approach is to integrate the biocompatible polymers with MSNs. Polymers including polyethylene glycol (PEG), polyethylenimine (PEI) and chitosan have been demonstrated to be excellent surface coating agents for MSNs, which can substantially enhance the in vivo circulation time, decrease cytotoxicity and hemolytic effect of MSNs. 295, 296, 297, 298 In terms of decreasing protein adsorption and boosting the colloidal stability of the particles, PEG is at present considered as an extremely excellent polymer. 298, 299, 300 Hao et al. systematically investigated the hemolytic activity and protein adsorption behavior of bare MSNs, MSNs modified with chitosan (MSNs-CS) and MSNs co-modified with chitosan and PEG (MSNs-CS-PEG). 301 Results showed that the hemolysis percentage and protein adsorption of MSNs-CS-PEG were 2% and 3.2%, respectively, which were remarkably lower than those of bare MSNs (30.9% and 14.5%, respectively), and they also exhibited lower toxicity toward MCF-7 cells. 301 This was similarly demonstrated in a study by He et al. 302 As well as polymers, liposomes have the advantages of high biocompatibility, low immunogenicity and long circulation, thereby they can also be used to enhance the biosafety of MSNs. 303, 304, 305 MSNs can be encapsulated by lipid bilayers or multilayers, and these liposomes act as protective shells to reduce toxicity by masking the reactive groups on the surface of MSNs. Compared to bare MSNs, liposome-encapsulated MSNs exhibit superior particle dispersion and lower non-specific binding. 306, 307 Additionally, they lead to the higher bioavailability and the in vivo half-life can be prolonged more than 10-fold, reducing the distribution of MSNs in reticuloendothelial system (RES)-related organs. 306 Protein coating is also a way to boost the biocompatibility and particle stability of MSNs. 308, 309 Negatively charged bull serum albumin (BSA), which is highly physiologically stable during blood circulation, can tightly bind to the amino groups on the MSNs surface, preventing the premature release of drug loaded on the MSNs. 309 Apart from, given that the positively charged MSNs show significant toxicity influence, some researchers have devoted to regulating the surface properties of MSNs by direct group modification. The surface potential of MSNs can be regulated by diverse functionalization via carboxyl (-COOH), phenyl (-Ph), and methyl phosphonate (-PO 3 - ) groups with negative and neutral zeta potentials. 310, 311
Silica for Beer Clarification: How Silica Gel Improves Beer Stability
Silica Manufacturer in India: Key Producers, Product Ranges and Export Capabilities
Clinical trials involving mesoporous silica have been ongoing since 2007, discussing its potential in diverse biomedical applications (Table 3 ). To date, the clinical trials have revealed the safety and good tolerability of silica in human subjects. In 2014, MSNs as oral delivery carriers for boosting the pharmacokinetic profile of drugs with limited aqueous solubility were reported. 500 A silica NPs-lipid hybrid formulation loading with ibuprofen (Lipoceramic-IBU) was prepared. The randomized, double-blind, single-dose oral administration study (20 mg ibuprofen) was conducted on 16 healthy male volunteers. The bioavailability of Lipoceramic-IBU was found to be 1.95 times higher than that of the commercial tablet Nurofen. 500 This result suggested the secure and effective use of silica-based NPs in mimicking food impacts to optimize the oral absorption of drugs with poor water solubility. In another clinical trial consisting of 12 participants in 2016, the bioavailability of ordered MSNs-based fenofibrate formulation raised by 54.1% after a single oral dose, when compared to the commercial formulation Lipanthyl. 39 Owing to the potentially perfect clinical outcomes of silica-based nanocarriers, the pharmacokinetics, safety, and metabolic profile of a hybrid core-shell silica NP (named Cornell dots, C dots) with a diameter of 6 nm functionalized with 124 I, targeting peptide cyclo-(Arg-Gly-Asp-Tyr), and Cy5 ( 124 I-cRGDY-PEG-C' dots) is first conducted in humans utilizing PET imaging and clinical tracer at clinical trials in 2014 (NCT01266096). 58 Results showed the good safety and reproducible PK signatures of C dots with the whole-body clearance half-time of 13-21 h after intravenous administration in patients, which is shorter than 111 In labeled liposomes and 131 I-labeled humanized monoclonal antibody A33. These findings verified the possibility of these NPs for cancer diagnostics in humans. 58 Similarly, 8 nm core-shell silica NPs encapsulated with Cy5.5 in the core and connected with cRGDY on the surface (cRGDY-PEG-Cy5.5-nanoparticles) were used in patients at nanomole doses for sentinel lymph nodes detection of head and neck melanoma at a phase 1/2 human clinical trial. 501 The incredible safety, accuracy, reliability, and high contrast of these particles for visual identification of sentinel lymph nodes are irreplaceable by other available imaging molecules presently, of which phase 2 clinical trial is ongoing and will be finished in 2024 (NCT02106598). Meanwhile, another two clinical trials based on C dots are carried out. In 2018, the 89 Zr-DFO-cRGDY-PEG-Cy5-C' dots tracers were first used in both surgical and non-surgical patients for PET-CT imaging of malignant brain tumors in phase 1 clinical trial (NCT03465618). The distribution and removal profiles from the body of these particles will also be assessed till 2023. In 2019, 64 Cu-NOTA-PSMA-PEG-Cy5.5-C' dots tracer was used in another human phase 1 clinical trial for guiding the surgery of prostate cancer by PET and MRI imaging (NCT04167969).As a nanocomposite with high safety and brilliant photothermal conversion efficiency, the silica-gold NPs have also been shown to be potential therapeutic agents for plasmonic photothermal therapy of atherosclerosis (NCT01270139), 502, 503 and photothermal ablation of tumors (NCT00848042, NCT04240639). 40 In addition, an engineered mesoporous silica (SiPore15) with particle size of 1.1-1.5 μm × 0.2-0.4 μm was developed by Baek et al., and they revealed that such pure synthetic amorphous silica could remarkably decrease long-term blood glucose levels, showing good promise for the treatment of prediabetes (NCT03823027). 504 In other clinical trials, an amorphous silica-containing bioactive scaffold, called Siloss, was used to promote bone regeneration, and could be replaced by natural bone due to its fully resorbable nature (NCT02639572), and the silica-calcium phosphate nanocomposite (SCPC) was developed as graft material for the reconstruction of the volume-deficient alveolar ridges (NCT05317039). In all, these clinical trials reveal the safety and efficacy of MSNs in diverse biomedical application scenarios.
What Is the Molar Mass of Silicon Dioxide (SiO₂)? Calculation Explained

Aluminum Silicate vs Silica: Composition, Properties and Uses Compared

What is silica (SiO₂)?

silica Alibaba

What is the difference between fumed silica and precipitated silica?

silica in cosmetics safe

What drives silica raw material prices?

quartz powder supplier

Cite this article: Silica Raw Materials News. "Silica as a Toothpaste Abrasive: How It Cleans and How RDA Is Controlled ." Published 2026-11-20 10:59:54. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.